Cargando…
Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
BACKGROUND: MDS1 and EVI1 complex locus protein EVI1 (MECOM) is an oncogenic transcription factor in several kinds of cancers. However, the clinical significance of MECOM in glioblastoma multiforme (GBM) has not been well elucidated. PATIENTS AND METHODS: Our study enrolled 86 resected samples of GB...
Autores principales: | Hou, Aiwu, Zhao, Lizhen, Zhao, Fuzhen, Wang, Weiliang, Niu, Jianyi, Li, Bingxuan, Zhou, Zhongjin, Zhu, Dongyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716764/ https://www.ncbi.nlm.nih.gov/pubmed/26834490 http://dx.doi.org/10.2147/OTT.S95831 |
Ejemplares similares
-
Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023) -
Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma
por: Chen, Peng, et al.
Publicado: (2018) -
Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis()
por: Zhu, Junle, et al.
Publicado: (2017) -
Epigenetic landscape reveals MECOM as an endothelial lineage regulator
por: Lv, Jie, et al.
Publicado: (2023) -
High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)